Endovascular Therapy Demonstrates Benefit Over Intravenous Recombinant Tissue Plasminogen Activator Based on Repeatedly Measured National Institutes of Health Stroke Scale

Interventional Neurology - Switzerland
doi 10.1159/000452137

Related search